• BIVDA members area

Members' Press Releases

From the monthly archives: July, 2016

We are pleased to present below all posts archived in 'July, 2016'. If you still can't find what you are looking for, try using the search box.

BBI Solutions extends its antibodies range

BBI Solutions

BBI Solutions (BBI) has vastly increased its antibodies range across a wide variety of disease areas including bone metabolism, cardiac, growth factors, thyroid, and sepsis. This range extension has been in response to growing demand in the IVD market. 

Read the rest of entry »

Trading Update and Notice of Results

Proteome Sciences

The Company is pleased to provide a trading update for the six months ending 30thJune 2016.  

Read the rest of entry »

Cytox launches breakthrough genetic biomarker research assay for Alzheimer’s disease

Cytox

Simple blood-based test will help reduce screening failure in clinical trials and assist drug discovery.

Read the rest of entry »

Cytox launches interpretive software for breakthrough genetic biomarker research assay for Alzheimer’s risk assessment at AAIC

Cytox

Combination will identify amyloid-positive subjects more efficiently and help reduce screening failure rates in clinical trials.

Read the rest of entry »

BBI Solutions new SCIPAC Clinical Specimen Panels, speeding up assay development for infectious diseases

BBI Solutions

BBI Solutions (BBI) today announced the launch of SCIPAC Clinical Specimen Panels. SCIPAC are quantitative panels of clinical specimen, collected from multiple donors of known genotype. 

Read the rest of entry »

Export Award Winner Attending AACC

BBI Solutions

BBI Solutions (BBI), recent winners of the Made in the UK Export Award, will be attending the AACC Clinical Lab Expo in Philadelphia next month. 

Read the rest of entry »

National Institute for Health and Care Excellence backs blood test for liver disease

Siemens 

Organisation recommends simple blood test for diagnosing liver fibrosis in people with Non Alcoholic Fatty Liver Disease (NAFLD)

  • An estimated 14 to 27 percent of the general population in the industrialised world has NAFLD1, which is often caused by obesity
  • The ADVIA Centaur ELF Test is an easy, standardised, accurate, minimally-invasive blood test that measures liver damage, also known as fibrosis
  • The ELF test is convenient to request compared to biopsy and/or scan, since it requires only a routine blood sample with test results available within an hour

Read the rest of entry »

Archive